Periodic Reporting for period 3 - MATRIX (Novel mitochondria-targeted therapies for cancer treatment-induced cardiotoxicity)

Every year, more that 4 million European are diagnosed with cancer, and 80% of them receive anthracyclines as part of the chemotherapy combination. Cancer Therapy-induced CardioToxicity (CTiCT) is a major health issue. Up to 30% of cancer survivors develop chronic heart...